How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

The UK Prospective Diabetes Study (UKPDS) is a landmark study that has significantly influenced the management of type 2 diabetes (T2D). The study by Stratton et al., published in BMJ in 2000, explores the relationship between glycaemic control and the risk of macrovascular and microvascular complications in patients with T2D. This summary highlights the key findings and their implications for clinical practice.

The UKPDS was a prospective observational study involving 4,585 patients with newly diagnosed T2D. The study aimed to determine how long-term glycaemic control, measured by HbA1c levels, affects the incidence of various diabetic complications. Data were collected over a median follow-up period of 10 years.

Key Highlights

1. Risk Reduction:
   Each 1% reduction in updated mean HbA1c was associated with significant reductions in the risk of complications:
    
   • 21% reduction in any diabetes-related endpoint.
   • 21% reduction in diabetes-related deaths.
   • 14% reduction in myocardial infarction.
   • 37% reduction in microvascular complications.

1. Hide text
2. No Threshold Effect:
   The study found no specific HbA1c threshold below which the risk of complications markedly decreased. Instead, the risk of complications continuously decreased with lower HbA1c levels.
    
3. Consistent Benefits:
   The benefits of improved glycaemic control were consistent across different types of complications, emphasizing the importance of maintaining lower HbA1c levels to reduce overall risk.

Conclusion

Clincal implications for General Practice

Healthcare providers should focus on:

By prioritizing these strategies, healthcare providers can help patients with T2D achieve better glycaemic control and reduce the incidence of diabetes-related complications.